These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 18704974)
1. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Hinerman RW; Amdur RJ; Morris CG; Kirwan J; Mendenhall WM Head Neck; 2008 Nov; 30(11):1431-8. PubMed ID: 18704974 [TBL] [Abstract][Full Text] [Related]
2. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy. Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for benign head and neck paragangliomas: a 45-year experience. Gilbo P; Morris CG; Amdur RJ; Werning JW; Dziegielewski PT; Kirwan J; Mendenhall WM Cancer; 2014 Dec; 120(23):3738-43. PubMed ID: 25060724 [TBL] [Abstract][Full Text] [Related]
4. Paraganglioma of the head and neck: long-term local control with radiotherapy. Chino JP; Sampson JH; Tucci DL; Brizel DM; Kirkpatrick JP Am J Clin Oncol; 2009 Jun; 32(3):304-7. PubMed ID: 19433962 [TBL] [Abstract][Full Text] [Related]
5. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Hinerman RW; Mendenhall WM; Amdur RJ; Stringer SP; Antonelli PJ; Cassisi NJ Head Neck; 2001 May; 23(5):363-71. PubMed ID: 11295809 [TBL] [Abstract][Full Text] [Related]
6. Excellent local control of paraganglioma in the head and neck with fractionated radiotherapy. Lightowlers S; Benedict S; Jefferies SJ; Jena R; Harris F; Burton KE; Burnet NG Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):382-9. PubMed ID: 20206483 [TBL] [Abstract][Full Text] [Related]
7. Treatment of head and neck paragangliomas with external beam radiation therapy. Dupin C; Lang P; Dessard-Diana B; Simon JM; Cuenca X; Mazeron JJ; Feuvret L Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):353-9. PubMed ID: 24685154 [TBL] [Abstract][Full Text] [Related]
8. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794 [TBL] [Abstract][Full Text] [Related]
9. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144 [TBL] [Abstract][Full Text] [Related]
10. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. Alektiar KM; Brennan MF; Healey JH; Singer S J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160 [TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for paragangliomas of the temporal bone. Boyle JO; Shimm DS; Coulthard SW Laryngoscope; 1990 Aug; 100(8):896-901. PubMed ID: 2166194 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895 [TBL] [Abstract][Full Text] [Related]
13. Paragangliomas of the temporal bone: results of different treatment modalities in 53 patients. Saringer W; Kitz K; Czerny C; Kornfehl J; Gstöttner W; Matula C; Knosp E Acta Neurochir (Wien); 2002 Dec; 144(12):1255-64; discussion 1264. PubMed ID: 12478336 [TBL] [Abstract][Full Text] [Related]
14. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065 [TBL] [Abstract][Full Text] [Related]
15. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Schoenfeld GO; Amdur RJ; Morris CG; Li JG; Hinerman RW; Mendenhall WM Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):377-85. PubMed ID: 18164838 [TBL] [Abstract][Full Text] [Related]
16. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529 [TBL] [Abstract][Full Text] [Related]
17. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Studer G; Luetolf UM; Glanzmann C Strahlenther Onkol; 2007 Aug; 183(8):417-23; discussion 424-5. PubMed ID: 17680220 [TBL] [Abstract][Full Text] [Related]
18. Management of jugular paragangliomas in otolaryngology practice. Karaman E; Yilmaz M; Isildak H; Hacizade Y; Korkut N; Devranoğlu I; Enver O; Sekercioglu N J Craniofac Surg; 2010 Jan; 21(1):117-20. PubMed ID: 20061964 [TBL] [Abstract][Full Text] [Related]
19. Conformal and stereotactic radiotherapy in hepatocellular carcinoma. Scorsetti M; Bignardi M Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272 [TBL] [Abstract][Full Text] [Related]
20. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Gomez DR; Hoppe BS; Wolden SL; Zhung JE; Patel SG; Kraus DH; Shah JP; Ghossein RA; Lee NY Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1365-72. PubMed ID: 18029108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]